FDI-03 Updated Clinical Report Page 77 Table 22 Distribution of DiseaseType by MenopausalStatusDisease Group Benign Low Malignant Potential Early Stage Epithelial Late Stage Epithelial Non-Epithelial Premenopausal MGH WIHRI Postmenopausal MGH ... women found to have benign gynecologic disease on surgery, 67 women with invasive ... malignant potential (borderline) tumors and 166 subjects with benign disease
genotype Age (years), mean ± SD FIGO stage I/II III/IV Hormonal Status Pre-menopause Post-menopause Residual Disease Optimal Surgery Residual tumor ≤ 2 cm Residual ... 88** FIGO stage I/II III/IV Hormonal Status Pre-menopause Post-menopause Residual ... types of band patterns were obtained: wild type homozygote (A/A), one band
the specific distribution (including International Classification of Diseases codes ... , or cancer of the ovary and female genital organs (n 54). Cancer types with fewer than 50
Pathology A Disease-free survival (%) Months after surgery British Journal of Cancer ... predicted a dismal prognosis regarding disease-free and overall survival, whereas ... . By multivariate analysis, nodal status, Ep-CAM overexpression, tumour size and histologic
correlation between Smac mRNA level and histology, menopause, clinical stage or disease ... there were no significant differences between clinical stages (Figure 3), menopausestatus (Figure 4) or diseasestatus (Figure 5). Similarly, a survival analysis of the patients showed
Table 1 Distribution of age, menopausalstatus, ultrasound score, serum CA125 and serum procollagen type III in 140 women with benign (n=80) and malignant (n=60) ovarian mass ... ></b> <span id="elem-275" style="font-size: 14pt;">Distribution of age, menopausalstatus, ultrasound score, serum CA125 and serum procollagen type III in 140 women with benign ... menopausalstatus had a sensitivity of 71% and specificity of 87% while ultrasound score
type, site, node metastasis, age at diagnosis and receptor status (estrogen ... include age at diagnosis (<50 years or ≥50 years), breast cancer type (ductal, lobular, invasive, inflammatory, or others), estrogen and progesterone receptor status ... ≤13 years >13 years Menopause Yes 93 (66.4) 47 (33.6) 40 (24.5) 123 (75.5) 75 (53.6) 65 (46.4) 89 (54.6) 74 (45.4) No Age at menopause <50 years ≥50 years Not Menopause Hormone Replacement Therapy Yes 41 (29.3) 35 (25) 64 (45.7) 60 (36.8) 29 (17
We next determined the distribution of demographic factors and cancer rates per 1000 screening mammograms by menopausalstatus (Table 1). The cancer rates suggest ... density, we computed the observed cancer risk without regard to menopausalstatus ... Not currently on HT Currently on HT Unknown Menopausetype Natural Surgical Unknown 18 183
findings for type 2 diabetes and those for cardiovascular disease suggest different ... activity, smoking, family history of diabetes, menopausalstatus, energy intake ... of type 2 diabetes. However, because the *2 allele tended to attenuate the lower risk
h (t) log G : 91.8792(treatment 9 0.47) ; 0.9644(menopausalstatus 9 0 ... disease (CVD). These participants, aged 50—79 years and free of CVD at the time ... or confirmed as a CVD death. CVD includes coronary heart disease (CHD) and stroke